Navigation Links
9/11's Health Effects Lingered for Years
Date:9/10/2008

Injured, workers and passersby developed psychological, respiratory woes, latest NYC report finds

WEDNESDAY, Sept. 10 (HealthDay News) -- Two to three years after the 9/11 terrorist attacks, psychological trauma and new respiratory problems were still elevated among people enrolled in the World Trade Center Health Registry, according to the latest New York City health department study.

Released on the eve of the seventh anniversary, the study looked at the health effects among all 71,437 participants of the registry, which includes rescue and recovery workers, lower Manhattan residents, area workers, commuters and passersby. Among the registrants: more than half reported being in the dust cloud from the collapsing World Trade Center towers; 70 percent witnessed a traumatic sight, such as a plane hitting a tower; and 13 percent suffered an injury on 9/11.

Those 71,437 people represent only about 17.4 percent of people whose exposure to the disaster would have made them eligible to enroll in the registry.

Two to three years after 9/11, 3 percent of all adult enrollees reported they'd developed new asthma, 16 percent had post-traumatic stress disorder (PTSD), and 8 percent had severe psychological distress, according to the study, published in the Journal of Urban Health.

Rescue and recovery workers who worked on the debris pile had the highest rate of new asthma (6 percent), while the PTSD rate was highest among injured (35 percent), low-income (31 percent) and Hispanic (30 percent) enrollees. Overall, minorities, people with low incomes, and women experienced higher rates of mental and physical problems.

Based on the figures from the registry, the study authors estimated that more than 400,000 people were exposed to the WTC disaster, 35,000 to 70,000 developed PTSD, and 3,800 to 12,600 people developed asthma as a result of the day's events.

The study found that 3 percent of L
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Anthem Blue Cross and Blue Shield Staff to Participate in WTMJ-TV Health Insurance Phone Bank
2. Healthcare Product Regulatory Professionals to Convene in Boston for RAPS Annual Conference & Exhibition
3. SSI Announces Agreement with Siemens Healthcare
4. Guardian Survey: Men are Twice as Likely as Women to Use Credit Cards to Pay for Major Health Expenses
5. Social Network For Affordable Health Care Supporters Stimulates A New Level of Interactivity and Dialogue
6. Allsup's New Medicare Advisor Program Helps People with Disabilities Make Sound Healthcare Coverage Decisions
7. Pediatrichealthchannel.com - New Site for Parents Seeking Answers to Children's Health Questions
8. Urgently Needed Database Now Available for People Who Cannot Afford Health Care at NeedyMeds.com
9. Retail medical clinics attract patients who do not have regular health care providers
10. Social Network for Affordable Health Care Supporters Stimulates a New Level of Interactivity and Dialogue
11. Governor Rendell Announces Resignation of Health Secretary Dr. Calvin Johnson
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
9/11's Health Effects Lingered for Years
9/11's Health Effects Lingered for Years
Breaking Medicine Technology:Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 2Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 3BMP Sunstone Announces the Inclusion of Seventy Eight Drugs in China's National Insurance Catalog 2BMP Sunstone Announces the Inclusion of Seventy Eight Drugs in China's National Insurance Catalog 3Elsevier Selects BrainTrack Directory as Supplier of College Data 2Elsevier Selects BrainTrack Directory as Supplier of College Data 3Elsevier Selects BrainTrack Directory as Supplier of College Data 4Welcome to the Biofuel Age of Flight 12593 1Welcome to the Biofuel Age of Flight 12593 2Welcome to the Biofuel Age of Flight 12593 3Students May Be Solution to Shortage of Medical Professionals 48719 1Students May Be Solution to Shortage of Medical Professionals 48719 2Students May Be Solution to Shortage of Medical Professionals 48719 3Students May Be Solution to Shortage of Medical Professionals 48719 4Hey Governator 21 Dont Terminate Senior Funding 21 48717 1Hey Governator 21 Dont Terminate Senior Funding 21 48717 2Hey Governator 21 Dont Terminate Senior Funding 21 48717 3Hey Governator 21 Dont Terminate Senior Funding 21 48717 4Hey Governator 21 Dont Terminate Senior Funding 21 48717 5
Other Medicine Technology:Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 2Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 3Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 4Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 5Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 6Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 7Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 8BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 2BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 3BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 4BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 5BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 6BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 7